Case Reports

Tissue Necrosis After Use of Enoxaparin in Total Knee Arthroplasty: A Case Report

Author and Disclosure Information

Tissue necrosis at the injection site of enoxaparin is a rare adverse effect. Most of the reported clinical course of this necrosis is uneventful. Here we review a case of tissue necrosis that developed after use of enoxaparin and required debridement followed by reconstructive surgery. Until now, such a case has not been reported in the English-language literature. As enoxaparin is being used more often for prevention of deep vein thrombosis in patients who undergo arthroplasty surgery, aware­ness and recognition of this adverse event and careful supervision of all patients who receive this medication are essential.


 

Recommended Reading

Management of Simultaneous Ipsilateral Dislocation of Hip, Knee, and Ankle
MDedge Surgery
Posterior Remodeling of Medial Clavicle Causing Superior Vena Cava Impingement
MDedge Surgery
The MRI Geyser Sign: Acromioclavicular Joint Cysts in the Setting of a Chronic Rotator Cuff Tear
MDedge Surgery
"Grand Piano Sign," a Marker for Proper Femoral Component Rotation During Total Knee Arthroplasty
MDedge Surgery
New Products/Product News
MDedge Surgery
Tibial Plateau "Kissing Lesion" From a Proud Osteochondral Autograft
MDedge Surgery
Spontaneous Disappearance of an Acromioclavicular Joint Cyst: A Case Report
MDedge Surgery
Axillary Artery Thrombosis After Humeral Resurfacing Arthroplasty
MDedge Surgery
Tibial Avascular Necrosis After Conversion From High Tibial Osteotomy to Total Knee Arthroplasty
MDedge Surgery
Acromial Fracture After Reverse Shoulder Arthroplasty
MDedge Surgery